PMV Pharmaceuticals Inc.

NASDAQ: PMVP · Real-Time Price · USD
1.50
-0.05 (-3.23%)
At close: Aug 15, 2025, 3:59 PM
1.52
1.00%
After-hours: Aug 15, 2025, 04:04 PM EDT

PMV Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
40.88M 37.71M 108.3M 172.47M
Short-Term Investments
128.58M 165.35M 132.76M 124.7M
Long-Term Investments
13.84M 25.5M 2.5M 16.91M
Other Long-Term Assets
235K 190K 313K 221K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
6.2M 4.35M 5.95M 822K
Total Current Assets
175.66M 207.41M 247.01M 301.29M
Property-Plant & Equipment
1.55M 19.05M 20.49M 13.15M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
15.63M 44.74M 23.3M 30.28M
Total Assets
191.29M 252.15M 270.31M 331.57M
Account Payables
6.58M 3.24M 3M 3.19M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
352K n/a 528K 403K
Other Current Liabilities
5M 4.5M 3.88M 4.43M
Total Current Liabilities
14.37M 14.03M 10.83M 12.22M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
838K 12.43M 13.45M 10.79M
Total Liabilities
15.21M 26.46M 24.28M 23.01M
Total Debt
1.19M 13.29M 13.98M 11.19M
Common Stock
n/a n/a n/a n/a
Retained Earnings
-368.71M -310M -241.04M -167.73M
Comprehensive Income
139K 224K -445K -78K
Shareholders Equity
176.08M 225.69M 246.03M 308.56M
Total Investments
142.42M 190.86M 135.25M 141.61M